Case Series: Sacubitril/Valsartan Role for Chemotherapy-Induced Cardiotoxicity: An in-Depth Investigation in Saudi Arabia.
Abdullah AlshammariBasmah Ahmed QasemNouf Ahmed AlmatrafiLujain Mofareh AlharbiAbeer Abdulhadi AlhuthaliAttiah Abdulrahman KhobraniMohammed A AlnuhaitPublished in: International medical case reports journal (2024)
Our case series provides significant insights by revealing improvements in ejection fraction (EF) in six out of eight patients who had chemotherapy-induced cardiomyopathy after receiving sacubitril/valsartan treatment.